Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 3, 2011, Pages 460-470

  Chen, Xiongwen ^a   Nakayama, Hiroyuki ^b   Zhang, Xiaoying ^a   Ai, Xiaojie ^a,c   Harris, David M ^d   Tang, Mingxin ^a   Zhang, Hongyu ^a   Szeto, Christopher ^a   Stockbower, Kathryn ^a   Berretta, Remus M ^a   Eckhart, Andrea D ^d   Koch, Walter J ^d   Molkentin, Jeffery D ^b   Houser, Steven R ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

2a Subunit; Hypertrophy; L type calcium channel (or Cav1.2); Transgenic mouse; Ventricular myocyte

Indexed keywords

CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL CAVBETA2A; CALCIUM CHANNEL L TYPE; CALCIUM ION; GREEN FLUORESCENT PROTEIN; HISTONE DEACETYLASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BODY WEIGHT; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CAT; CELL NUCLEUS MEMBRANE; CELL VOLUME; CONTROLLED STUDY; CYTOSOL; FEMALE; HEART EJECTION FRACTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE FIBROSIS; HEART VENTRICLE SEPTUM; HEART WEIGHT; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CALCINEURIN; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CARDIOMEGALY; CATS; HEART VENTRICLES; HISTONE DEACETYLASES; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; NUCLEAR ENVELOPE; PHENOTYPE; RATS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; FELIDAE; MUS; MUS MUSCULUS; RATTUS;

EID: 79551611533     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.11.012     Document Type: Article

References (34)

1. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006 Aug, 7(8):589-600.
2. Bristow M.R., Kantrowitz N.E., Ginsburg R., Fowler M.B. Beta-adrenergic function in heart muscle disease and heart failure. J Mol Cell Cardiol 1985 Jul, 17(Suppl 2):41-52.
3. Dorn G.W. Adrenergic pathways and left ventricular remodeling. J Card Fail 2002 Dec, 8(6 Suppl):S370-S373.
4. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005 Apr, 11(4):409-417.
5. 2+ channel. Circ Res 2009 Jul 2, 105(1):51-60.
6. Semsarian C., Ahmad I., Giewat M., Georgakopoulos D., Schmitt J.P., McConnell B.K., et al. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Investig 2002 Apr, 109(8):1013-1020.
7. Liao Y., Asakura M., Takashima S., Ogai A., Asano Y., Asanuma H., et al. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice. Cardiovasc Res 2005, 65(4):879-888.
8. Chiang C.S., Huang C.H., Chieng H., Chang Y.T., Chang D., Chen J.J., et al. The Ca(v)3.2T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 2009 Feb 27, 104(4):522-530.
9. Onohara N., Nishida M., Inoue R., Kobayashi H., Sumimoto H., Sato Y., et al. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J 2006 Nov 15, 25(22):5305-5316.
10. Cingolani E., Ramirez Correa G.A., Kizana E., Murata M., Cho H.C., Marban E. Gene therapy to inhibit the calcium channel beta subunit: physiological consequences and pathophysiological effects in models of cardiac hypertrophy. Circ Res 2007 Jul 20, 101(2):166-175.
11. Ikeda K., Tojo K., Tokudome G., Akashi T., Hosoya T., Harada M., et al. Possible involvement of endothelin-1 in cardioprotective effects of benidipine. Hypertens Res 2000 Sep, 23(5):491-496.
12. 2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats. Hypertens Res 2002 Jan, 25(1):117-124.
13. 2+ signal integrators. Proc Natl Acad Sci USA 2008 Feb 26, 105(8):2859-2864.
14. 2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy. Cardiology 2007, 107(4):281-290.
15. Muth J.N., Bodi I., Lewis W., Varadi G., Schwartz A. A Ca(2+)-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation 2001 Jan 2, 103(1):140-147.
16. Huang C.Y., Hao L.Y., Buetow D.E. Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium-channel-dependent. Mol Cell Biochem 2002 Feb, 231(1-2):51-59.
17. 2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Investig 2007 Sep, 117(9):2431-2444.
18. Seth M., Zhang Z.S., Mao L., Graham V., Burch J., Stiber J., et al. TRPC1 channels are critical for hypertrophic signaling in the heart. Circ Res 2009 Nov 6, 105(10):1023-1030.
19. 2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers. Life Sci 2008 Mar 12, 82(11-12):554-560.
20. Sanbe A., Gulick J., Hanks M.C., Liang Q., Osinska H., Robbins J. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 2003 Apr 4, 92(6):609-616.
21. 2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ Res 2005 Nov 11, 97(10):1009-1017.
22. Chen X., Wilson R.M., Kubo H., Berretta R.M., Harris D.M., Zhang X., et al. Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res 2007 Mar 2, 100(4):536-544.
23. Tang M., Zhang X., Li Y., Guan Y., Ai Y., Szeto C., et al. Enhanced basal contractility but reduced excitation-contraction coupling efficiency and {beta}-adrenergic reserve of hearts with increased Cav1.2 activity. Am J Physiol Heart Circ Physiol 2010 Aug, 299(2):H519-H528.
24. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Investig 2006 Mar, 116(3):675-682.
25. 2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes?. Sci Signal 2008, 1(25):pe31.
26. 2+ overload to induce cardiac arrhythmia but with shortened QT and action potentials (Abstract 2733). Circulation 2009, 120:689.
27. Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A., et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin Investig 2006 Dec, 116(12):3114-3126.
28. Hunton D.L., Lucchesi P.A., Pang Y., Cheng X., Dell'Italia L.J., Marchase R.B. Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes. J Biol Chem 2002 Apr 19, 277(16):14266-14273.
29. Nuss H.B., Houser S.R. T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 1993 Oct, 73(4):777-782.
30. 2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Investig 2009 Dec, 119(12):3787-3796.
31. 2+ release is a nexus for hypertrophic signaling in cardiac myocytes. Mol Cell 2009 Feb 27, 33(4):472-482.
32. Rechavia E., de Silva R., Nihoyannopoulos P., Lammertsma A.A., Jones T., Maseri A. Hyperdynamic performance of remote myocardium in acute infarction. Correlation between regional contractile function and myocardial perfusion. Eur Heart J 1995, 16(12):1845-1850.
33. Hullin R., Matthes J., von Vietinghoff S., Bodi I., Rubio M., D'Souza K., et al. Increased expression of the auxiliary beta(2)-subunit of ventricular L-type Ca(2)+channels leads to single-channel activity characteristic of heart failure. PLoS ONE 2007, 2(3):e292.
34. Klingbeil A.U., Schneider M., Martus P., Messerli F.H., Schmieder R.E. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003 Jul, 115(1):41-46.